BioWorld - Monday, February 16, 2026

Articles Tagged with ''2021''

Handshake with digital globe overlay

Digital health dominated med-tech deal activity and drove record M&As in 2021

Jan. 21, 2022
By Karen Carey
In one of the most extraordinary years for med-tech mergers and acquisitions, 2021 is the culmination of a snowballing interest in maturing digital technologies amid mounting COVID-19 pandemic problems and uncertain futures. Societal lockdowns in 2020 boosted notice of telehealth, testing and remote monitoring devices, but that notice ramped up even more in 2021, not only as new SARs-CoV-2 variants emerged, but as businesses sought innovative ways of delivering their products.
Read More
Shipping container with flag of China

China med-tech exports declined in 2021 as imports increased

Jan. 5, 2022
By Zhang Mengying
China’s med-tech products exports declined in 2021 as manufacturing in other countries picked up, while med-tech imports to the country increased. In the first half of 2021, China’s med-tech exports amounted to $47.931 billion, a decrease of 23.1% year-on-year. But imports for the same period amounted to $24.392 billion, an increase of 25.2% year-on-year, according to med-tech data company Guangzhou Joinchain Big Data Technology Co. Ltd.
Read More

Top Trends of 2021: BioWorld looks back as we head into 2022

Dec. 28, 2021
Every year, the BioWorld team takes time to look back and assess the market-moving and life-changing stories and trends of the year. Without a doubt, COVID-19 shook humanity to the core, again. And like glioblastoma, the tentacles of COVID-19 invaded far beyond the obvious and ultimately changed the world. So that’s our top story of the year. But the biopharmaceutical industry is resilient and responsive. Even though there were tectonic shifts in efforts to bring an armamentarium of COVID-19 vaccines and therapeutics to patients with record-breaking speed, work continued on other fronts.
Read More
Artificial intelligence and digital health icons
A look back as we head into 2022

Top Med-tech Trends of 2021: As AI-enhanced radiology solutions proliferate, scaling them becomes the challenge

Dec. 22, 2021
By Annette Boyle
Announcements of new radiology solutions enhanced by artificial intelligence (AI) and machine learning appeared almost daily in 2021, all promising more accurate diagnoses in less time and increased productivity and confidence for radiologists. Hospitals and health care systems have increasingly recognized the advantages of these systems, with Sage Growth Partners reporting that 90% of hospitals have an AI strategy in place, up from 53% in 2019, but the deployment lags, with only 34% of hospitals having installed an AI solution.
Read More
Mental illness illustration
A look back as we head into 2022

Top Med-tech Trends of 2021: Differentiation will be key for plethora of mental health techs

Dec. 22, 2021
By Catherine Longworth
Investor appetite for digital mental health technologies is expected to continue in 2022, although startups will face the challenge of standing out from competition. Venture capital firm Rock Health reported funding for digital mental health startups was the top-funded therapeutic focus in 2021, with $3.1 billion raised by the end of Q3. Key trends are emerging, as investors seek companies addressing complex mental health conditions.
Read More

Top Trends of 2021: BioWorld looks back as we head into 2022

Dec. 22, 2021
Every year, the BioWorld team takes time to look back and assess the market-moving and life-changing stories and trends of the year. Without a doubt, COVID-19 shook humanity to the core, again. And like glioblastoma, the tentacles of COVID-19 invaded far beyond the obvious and ultimately changed the world. So that’s our top story of the year. But the biopharmaceutical industry is resilient and responsive. Even though there were tectonic shifts in efforts to bring an armamentarium of COVID-19 vaccines and therapeutics to patients with record-breaking speed, work continued on other fronts.
Read More
Patient using Predictix Genetics on tablet
A look back as we head into 2022

Top Med-tech Trends of 2021: Better therapy matching brings optimism to depression treatment

Dec. 21, 2021
By Annette Boyle
2021 may mark the beginning of a new phase in treatment of depression. While genetic matching of depression therapies to patients has been touted for a decade, meta-analyses have not supported claims of improved response rates with studies often finding that any improvements seen likely came from switching patients to guideline-recommended therapies rather than any insight from genetics.
Read More
doctor, checklist, apple, prescription bottle and blood glucose meter illustration
A look back as we head into 2022

Top Med-tech Trends of 2021: Diabetes market poised for growth, despite pandemic

Dec. 20, 2021
By Meg Bryant
Diabetes care will continue to evolve in 2022. New digital offerings and advanced algorithms, along with new product launches in insulin pumps and continuous glucose monitoring (CGM) will power growth in the future, according to key analysts. While many medical device sectors have suffered during the COVID-19 pandemic, diabetes care has continued to grow.
Read More
Handshake, businessmen holding dollar sign, lightbulb
A look back as we head into 2022

Top Med-tech Trends of 2021: Notable med-tech M&As close, value hits $145B, but deals way down

Dec. 17, 2021
By Karen Carey
Although 2021 med-tech deal volume is 13% higher than last year, the deals represent less than half the value recorded in 2020. The industry has completed 1,576 deals, including licensings, collaborations and joint ventures, through mid-December of 2021. They are valued at $2.13 billion. A total of 573 M&As, on the other hand, have reached $144.75 billion, a 282% rise over 2020.
Read More